BRISTOL-MYERS SQUIBB COMPANY Dividends, Cash
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Dividends, Cash of $2.40 billion for the 12-month period ending 2009-12-31, per its 10-K filed 2010-02-19.
Discontinued › Shareholders' Equity
us-gaap:DividendsCash · last filed 2010-02-19
- BRISTOL-MYERS SQUIBB COMPANY dividends, cash for the quarter ending 2009-12-31 was $552.00M, a 10.10% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY dividends, cash for the quarter ending 2008-12-31 was $614.00M.
- BRISTOL-MYERS SQUIBB COMPANY dividends, cash for fiscal 2009 was $2.40B, a 2.40% decline from fiscal 2008.
- BRISTOL-MYERS SQUIBB COMPANY dividends, cash for fiscal 2008 was $2.46B, a 8.13% increase from fiscal 2007.
- BRISTOL-MYERS SQUIBB COMPANY dividends, cash for fiscal 2007 was $2.27B.
| Period end | Dividends, Cash 3 month | Dividends, Cash 9 month | Dividends, Cash 12 month |
|---|---|---|---|
| 2009-12-31 | $552.00M derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-19 | $2.40B 10-K · filed 2010-02-19 | |
| 2009-09-30 | $1.85B 10-Q · filed 2009-10-22 | ||
| 2008-12-31 | $614.00M derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-19 | $2.46B 10-K · filed 2010-02-19 | |
| 2008-09-30 | $1.85B 10-Q · filed 2009-10-22 | ||
| 2007-12-31 | $2.27B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |